Italia markets closed
FTSE MIB
34.249,77 +310,02 (+0,91%) Dow Jones
38.239,66 +153,86 (+0,40%) Nasdaq
15.927,90 +316,14 (+2,03%) Nikkei 225
37.934,76 +306,28 (+0,81%) Petrolio
83,66 +0,09 (+0,11%) Bitcoin EUR
58.909,29 -1.239,77 (-2,06%)
Transgene SA (0OCQ.L)
LSE - LSE Prezzo differito. Valuta in EUR.
Aggiungi a watchlist
Alla chiusura: 05:10PM BST
| Chiusura precedente | 1,4880 |
| Aperto | 0,0000 |
| Denaro | 0,0000 x 0 |
| Lettera | 0,0000 x 0 |
| Min-Max giorno | 0,0000 - 0,0000 |
| Intervallo di 52 settimane | |
| Volume | |
| Media Volume | 520 |
| Capitalizzazione | 798.428 |
| Beta (5 anni mensile) | 0,72 |
| Rapporto PE (ttm) | N/D |
| EPS (ttm) | -0,2140 |
| Prossima data utili | N/D |
| Rendimento e dividendo (futuro) | N/D (N/D) |
| Data ex dividendo | N/D |
| Stima target 1A | N/D |
GlobeNewswireOne Biosciences announces the appointment of Hedi Ben Brahim as Chief Executive Officer
PARIS, Sept. 07, 2023 (GLOBE NEWSWIRE) -- One Biosciences, a biotech leveraging the power of single-cell analysis and AI to unlock a new wave of targets and precision medicines for a broad range of difficult-to-treat diseases, today announced the appointment of Mr. Hedi Ben Brahim as its Chief Executive Officer (CEO). Hedi is a recognized leader in the biotechnology industry, joining from Transgene (Euronext: TNG) where he served as Chief Executive Officer. Mr. Ben Brahim was appointed CEO as pa
© 2024 Yahoo. Tutti i diritti riservati.